Latest news

July 4, 2025 News

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year

SYDNEY, Australia – June 30, 2025. In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded...

Read more Notification Icon
June 24, 2025 News

Live Biotherapeutics at a Crossroad Novotech White Paper Outlines Opportunities and Early-Stage…

Sydney, Australia, June 2025 – As Live Biotherapeutic Product...

Read more Notification Icon
June 11, 2025 News

Novotech Showcased in Global Biotech Series for Innovation in Hepatitis B Research

Sydney, Australia, June 11, 2025, Novotech a globally recogni...

Read more Notification Icon
May 28, 2025 News

New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical…

Sydney, Australia – May 2025 – Novotech a globally recognized full-service cli...

Read more Notification Icon
View all news

Latest reports

April 19, 2025 Report

Obesity: Global Clinical Trial Landscape (2025)

Explore the evolving treatment landscape for obesity through Novotech CRO’s latest disease report....

Download
April 10, 2025 Report

Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025)

Discover the latest advancements in Idiopathic Pulmonary Fibrosis through Novotech CRO's in-depth disease analysis....

Download
February 26, 2025 Report

Hepatitis B: Global Clinical Trial Landscape (2025)

Discover the latest advancements in Hepatitis B through Novotech CRO's in-depth disease analysis....

Download
January 7, 2025 Report

Triple-Negative Breast Cancer: Global Clinical Trial Landscape (2024)

Discover the latest advancements in triple-negative breast cancer through Novotech CRO's in-depth disease analysis....

Download
View all reports

Latest whitepapers

July 2, 2025 Whitepaper

2025 Global Report for In-Vivo CAR Cell Therapy

Explore global trends shaping in-vivo CAR therapies—delivery innovations, clinical trial momentum, and regulatory strategies across oncology and autoimmune diseases....

Download
June 12, 2025 Whitepaper

Live Biotherapeutic Products Whitepaper 2025

Live biotherapeutic products (LBPs) are gaining momentum in the drug development space, emphasisin...

Download
March 19, 2025 Whitepaper

Optimizing siRNA Therapeutics: Addressing Nonclinical and Manufacturing Complexities

Recent FDA approvals of siRNA drugs have revolutionized drug development for this therapeutic modality, which leverag...

Download
March 10, 2025 Whitepaper

Stay Ahead of the Curve: Infectious Disease Clinical Trial Trends & Insights for 2025

Discover the latest data and strategic insights shaping the global infectious disease clinical trial landscape....

Download
View all whitepapers

Latest webinars

June 26, 2025 Webinar

Mitigating Risk with Ex-US Clinical Trials

This expert-led webinar explores how ex-US clinical trials can help biotech and mid-size pharma companies accelerate development…

Watch
May 27, 2025 Webinar

Navigating the Early Oncology Landscape: Market Trends and Insights

This presentation explores the evolving landscape of early-phase oncology clinical trials, offering key market trends and…

Watch
April 15, 2025 Webinar

Adapting to Change: What Pharma Companies Must Do to Prepare for RMP

Novotech is participating in the Adapting to Change: What Pharma Companies Must Prepare for with Risk Management Plans panel…

Watch
December 10, 2024 Webinar

Clinical Trials and the Evolving Global Standard of Care in Precision Oncology

This webinar will address the critical global disparities in the standard of care for precision medicine, focusing on access to…

Watch
View all webinars

Latest events

July 23-27, 2025 Events

BIO Asia–Taiwan 2025

Taipei

Read More
July 28, 2025 Events

Bio Connections Australia 2025

Crown Promenade, Melbourne, Australia

Read More
July 22-23, 2025 Events

Australia and New Zealand Site Solutions Summit 2025

Melbourne, Australia

Read More
June 27-28, 2025 Events

CBA China Annual Conference 2025

Suzhou, China

Read More
View all events

Latest articles

July 14, 2025 Article

Rethinking Clinical Trials: Yooni Kim on Why an Ex-US Strategy Accelerates Success

Amid growing delays and rising costs in U.S. clinical trials, biotechs are looking for smarter ways to accelerate development. Yooni...

Read more
July 8, 2025 Article

Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success

Discover how strong CRO-sponsor partnerships can drive clinical trial success through strategic collaboration, transparent communication, and shared performance goals. Learn...

Read more
June 30, 2025 Article

How a Tough Funding Climate is Reshaping US Clinical Trial Activity

Biotech sponsors are facing new pressures—and the effects are rippling through the clinical research landscape.In a recent feature by Clinical...

Read more
May 28, 2025 Article

New weight loss drugs: Biotech’s mission to end obesity

Obesity now affects over 2.5 billion adults and nearly 400 million children and teens worldwide, making it a leading driver...

Read more
View all articles

Latest blog

June 25, 2025 Blog

Accelerating Trial Start-Up: CRO Best Practices for 2025

What are the best ways to accelerate clinical trial start-up in 2025?...

Read more
June 5, 2025 Blog

What ASCO 2025 Means for the Future of Oncology Trials

Attending the ASCO Annual Meeting is always a timely pulse check on where oncology is headed and A...

Read more
June 2, 2025 Blog

Where Are the Major Clinical Research Pockets in the World?

Clinical research activity is heavily concentrated in global regions with strong healthcare infrastructure, skilled i...

Read more
May 5, 2025 Blog

What Is the Role of CROs in Drug Development?

Contract Research Organizations (CROs) play a pivotal role in accelerating drug development, optimizi...

Read more
View all blog

Latest case study

November 15, 2024 Case Study

Indian Biotech Phase IIB

BackgroundA biotech company based in India embarked on a Phase IIb clinical trial t...

Read More
April 24, 2024 Case Study

Examining a Phase 1 COVID 19 Clinical Trial

Background:Phase I clinical studies are critical in the development of new therapies especially in the rapidly changing biotech...

Read More
April 12, 2024 Case Study

Muscular Dystrophy – Multi-National and Multi-Site Trials Case Study

Company Background:ReveraGen BioPharma Inc., a clinical-stage drug development company based in the US, specializing in rare dis...

Read More
December 23, 2023 Case Study

Expert Consulting and Multi-Regional Clinical Trial (MRCT) Strategy Rescues Oncology Program

Background   A biotech sponsor based in China with a focus on innovating novel immunotherapy treatments, encountered...

Read More
View all case studies

Latest FAQs

July 2, 2025 FAQ

What makes in-vivo CAR therapies the next frontier in cell therapy?

Explore key questions and answers to learn how this innovative approach is transforming treatment possibilities. ...

Read More
June 12, 2025 FAQ

FAQs on Live Biotherapeutic Products

Live biotherapeutic products contain a single species or consortium of live microorganisms such as bacteria or yeast isolated from human...

Read More
April 22, 2025 FAQ

Overview of Obesity: Global Clinical Trials Landscape

Obesity is a chronic, progressive metabolic disease driven by excessive fat accumulation, increasing the risk of serious health conditions such...

Read More
April 10, 2025 FAQ

Overview of Idiopathic Pulmonary Fibrosis: Global Clinical Trials Landscape

Idiopathic Pulmonary Fibrosis is a highly infectious lung disease that can lead to chronic infection, cirrhosis, and cancer.&n...

Read More
View all faqs